MRI Techniques for Prediction of Local Tumor Progression After High-Intensity Focused Ultrasonic Ablation of Prostate Cancer
Chan Kyo Kim1,
Byung Kwan Park1,
Hyun Moo Lee2,
Sam Soo Kim3 and
EunJu Kim4
1 Department of Radiology and Center for Imaging Science, Samsung Medical
Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Kangnam-gu,
Seoul, Republic of Korea 135-710.
2 Department of Urology, Samsung Medical Center, Sungkyunkwan University School
of Medicine, Seoul, South Korea.
3 Department of Radiology, Kangwon National University School of Medicine,
Kangwon-do, South Korea.
4 Department of MRI, DIS Business Group, Philips Healthcare Korea, Seoul, South
Korea.

View larger version (164K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1A —66-year-old man with local tumor progression of prostate
cancer in left lobe (prostate-specific antigen level, 2.38 ng/mL; Gleason sum
score, 8). Axial T2-weighted turbo spin-echo MR image shows focal area
(arrow) of low signal intensity in left lobe.
|
|

View larger version (104K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1B —66-year-old man with local tumor progression of prostate
cancer in left lobe (prostate-specific antigen level, 2.38 ng/mL; Gleason sum
score, 8). Axial apparent diffusion coefficient map image corresponding to
A shows focal low-signal-intensity lesion (arrow) relative to
noncancerous prostate tissue.
|
|

View larger version (91K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1C —66-year-old man with local tumor progression of prostate
cancer in left lobe (prostate-specific antigen level, 2.38 ng/mL; Gleason sum
score, 8). Parametric images of wash-in rate (C), maximal enhancement
(D), and time-to-peak (E) show color-coded area (arrow)
corresponding to site in A and representing possibility of local tumor
progression. In this case, T2-weighted MRI with diffusion-weighted imaging was
equivalent to dynamic contrast-enhanced parametric imaging.
|
|

View larger version (95K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1D —66-year-old man with local tumor progression of prostate
cancer in left lobe (prostate-specific antigen level, 2.38 ng/mL; Gleason sum
score, 8). Parametric images of wash-in rate (C), maximal enhancement
(D), and time-to-peak (E) show color-coded area (arrow)
corresponding to site in A and representing possibility of local tumor
progression. In this case, T2-weighted MRI with diffusion-weighted imaging was
equivalent to dynamic contrast-enhanced parametric imaging.
|
|

View larger version (114K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1E —66-year-old man with local tumor progression of prostate
cancer in left lobe (prostate-specific antigen level, 2.38 ng/mL; Gleason sum
score, 8). Parametric images of wash-in rate (C), maximal enhancement
(D), and time-to-peak (E) show color-coded area (arrow)
corresponding to site in A and representing possibility of local tumor
progression. In this case, T2-weighted MRI with diffusion-weighted imaging was
equivalent to dynamic contrast-enhanced parametric imaging.
|
|

View larger version (153K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2A —69-year-old man with local tumor progression of prostate
cancer involving both lobes (prostate-specific antigen level, 4.31 ng/mL;
Gleason sum score, 7). Axial T2-weighted turbo spin-echo MR image shows
slightly low signal intensity (arrows) in both lobes.
|
|

View larger version (110K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2B —69-year-old man with local tumor progression of prostate
cancer involving both lobes (prostate-specific antigen level, 4.31 ng/mL;
Gleason sum score, 7). Axial apparent diffusion coefficient map image shows
slightly low signal intensity (arrows) in site corresponding to
A. Both readers interpreted lesion as noncancerous tissue.
|
|

View larger version (92K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2C —69-year-old man with local tumor progression of prostate
cancer involving both lobes (prostate-specific antigen level, 4.31 ng/mL;
Gleason sum score, 7). Parametric images of wash-in rate (C), maximal
enhancement (D), maximal relative enhancement (E), and
time-to-peak (F) show color-coded area (arrows) in site
corresponding to A, representing possibility of local tumor
progression. In this case, dynamic contrast-enhanced parametric images were
superior to T2-weighted MRI with diffusion-weighted imaging.
|
|

View larger version (90K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2D —69-year-old man with local tumor progression of prostate
cancer involving both lobes (prostate-specific antigen level, 4.31 ng/mL;
Gleason sum score, 7). Parametric images of wash-in rate (C), maximal
enhancement (D), maximal relative enhancement (E), and
time-to-peak (F) show color-coded area (arrows) in site
corresponding to A, representing possibility of local tumor
progression. In this case, dynamic contrast-enhanced parametric images were
superior to T2-weighted MRI with diffusion-weighted imaging.
|
|

View larger version (100K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2E —69-year-old man with local tumor progression of prostate
cancer involving both lobes (prostate-specific antigen level, 4.31 ng/mL;
Gleason sum score, 7). Parametric images of wash-in rate (C), maximal
enhancement (D), maximal relative enhancement (E), and
time-to-peak (F) show color-coded area (arrows) in site
corresponding to A, representing possibility of local tumor
progression. In this case, dynamic contrast-enhanced parametric images were
superior to T2-weighted MRI with diffusion-weighted imaging.
|
|

View larger version (127K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2F —69-year-old man with local tumor progression of prostate
cancer involving both lobes (prostate-specific antigen level, 4.31 ng/mL;
Gleason sum score, 7). Parametric images of wash-in rate (C), maximal
enhancement (D), maximal relative enhancement (E), and
time-to-peak (F) show color-coded area (arrows) in site
corresponding to A, representing possibility of local tumor
progression. In this case, dynamic contrast-enhanced parametric images were
superior to T2-weighted MRI with diffusion-weighted imaging.
|
|

View larger version (155K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3A —73-year-old man with false-positive findings on dynamic
contrast-enhanced parametric imaging (prostate-specific antigen level, 1.89
ng/mL). Axial T2-weighted turbo spin-echo (A) and apparent diffusion
coefficient map (B) images show slightly diffuse low signal intensity
(arrows) in both lobes. Finding is suggestive of noncancerous
tissue.
|
|

View larger version (83K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3B —73-year-old man with false-positive findings on dynamic
contrast-enhanced parametric imaging (prostate-specific antigen level, 1.89
ng/mL). Axial T2-weighted turbo spin-echo (A) and apparent diffusion
coefficient map (B) images show slightly diffuse low signal intensity
(arrows) in both lobes. Finding is suggestive of noncancerous
tissue.
|
|

View larger version (104K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3C —73-year-old man with false-positive findings on dynamic
contrast-enhanced parametric imaging (prostate-specific antigen level, 1.89
ng/mL). Parametric images of maximal enhancement (C), maximal relative
enhancement (D), and washout rate (E) show color-coded area
(arrowheads) in site corresponding to A and representing
possibility of local tumor progression. Findings at transrectal
sonographically guided prostate biopsy showed benign prostate gland and stroma
without cancer foci. In this case, T2-weighted MRI with diffusion-weighted
imaging was superior to dynamic contrast-enhanced parametric imaging.
|
|

View larger version (108K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3D —73-year-old man with false-positive findings on dynamic
contrast-enhanced parametric imaging (prostate-specific antigen level, 1.89
ng/mL). Parametric images of maximal enhancement (C), maximal relative
enhancement (D), and washout rate (E) show color-coded area
(arrowheads) in site corresponding to A and representing
possibility of local tumor progression. Findings at transrectal
sonographically guided prostate biopsy showed benign prostate gland and stroma
without cancer foci. In this case, T2-weighted MRI with diffusion-weighted
imaging was superior to dynamic contrast-enhanced parametric imaging.
|
|

View larger version (104K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3E —73-year-old man with false-positive findings on dynamic
contrast-enhanced parametric imaging (prostate-specific antigen level, 1.89
ng/mL). Parametric images of maximal enhancement (C), maximal relative
enhancement (D), and washout rate (E) show color-coded area
(arrowheads) in site corresponding to A and representing
possibility of local tumor progression. Findings at transrectal
sonographically guided prostate biopsy showed benign prostate gland and stroma
without cancer foci. In this case, T2-weighted MRI with diffusion-weighted
imaging was superior to dynamic contrast-enhanced parametric imaging.
|
|

View larger version (21K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4 —Receiver operating characteristic curves show results of
interpretation of dynamic contrast-enhanced MRI (DCE-MRI) and T2-weighted MRI
with diffusion-weighted imaging (DWI) by two readers. No statistical
difference between DCE-MRI and T2-weighted MRI with DWI for two readers was
evident for prediction of local tumor progression of prostate cancer after
high-intensity focused ultrasonic ablation. Az = area
under the receiver operating characteristic curve.
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Copyright © 2008 by the American Roentgen Ray Society.